XBP1 and Miyoshi myopathy: The inhibition of IRE1α endoribonuclease domain and therefore of XBP1 splicing was also proposed as a promising strategy to reduce the MM cell capacity of coping with the proteotoxic stress and kill MM cells (65, 66).